NRG Oncology Awarded NCI Funding for Next 6 Years, Receives “Exceptional” Score

The National Cancer Institute (NCI) has awarded NRG Oncology over $95 Million to support our work over the next six years as a lead protocol organization program in NCI’s National Clinical Trials Network. In this review process, NRG Oncology received an "exceptional" score of 16! We published over fifty practice-changing or practice-defining observations in our first four years of operation, and these accomplishments were cited in this highly favorable review. As we enter into this new grant cycle, NRG Oncology leadership is developing strategic priorities which will evolve the conduct of our trials and expand the reach of our research.

We extend our deepest appreciation to all NRG Oncology members for volunteering your time and expertise in pursuit of improving the lives of cancer patients through our research programs!!!

Walter J. Curran, Jr., MD
Robert S. Mannel, MD
Norman Wolmark, MD
View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from to
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Update Profile/Email Address | Forward Email | Report Abuse